encyclopedia of medical concepts
ψ 
ψ 
ψ 
ψ 
ψ 
ψ 
ψ 
ψ 

Mucopolysaccharidosis II

More information in Books or onNLM PubMed
Definition: Systemic lysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of L-sulfoiduronate sulfatase. This disease differs from MUCOPOLYSACCHARIDOSIS I by slower progression, lack of corneal clouding, and X-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15.  DF: MPS II   
See Also Iduronate Sulfatase; Mucopolysaccharidosis I
Other names Sulfoiduronate Sulfatase Deficiency; Iduronate Sulfatase Deficiency; Iduronate 2-Sulfatase Deficiency; Hunter's Syndrome; Gargoylism, Hunter Syndrome; Type 2s, Mucopolysaccharidosis; Type 2, Mucopolysaccharidosis; Syndrome, Hunter's; Sulfoiduronate Sulfatase Deficiencies; Sulfatase Deficiency, Sulfoiduronate; Sulfatase Deficiency, Iduronate; Sulfatase Deficiencies, Sulfoiduronate; Sulfatase Deficiencies, Iduronate; Mucopolysaccharidosis Type 2s; Mucopolysaccharidosis IIs; Iduronate Sulfatase Deficiencies; Iduronate 2-Sulfatase Deficiencies; Iduronate 2 Sulfatase Deficiency; IIs, Mucopolysaccharidosis; Hunters Syndrome

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012

Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify.
We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy